A large retrospective review of 3,126 patients with chronic wounds treated with multimodality intermittent topical oxygen therapy (ITOT) presented at the 2026 American Venous Forum (AVF; 28 February–March 4, Denver, USA) demonstrated superior and more durable wound healing outcomes in complex, comorbid populations compared to those reported in population-based, real-world studies, according to study data. Presenter Johann Lohr (Columbia, USA) talks to Venous News about the results.
The materials presented here solely represent the views of the author and do not represent the view of the US Department of Veterans Affairs or the United States government. The presenter was not compensated for this presentation.
